Glenmark Pharma Indore Plant Gets USFDA Warning Letter
Glenmark Indore USFDA Glenmark Indore USFDA: Glenmark Pharmaceuticals has received a warning letter from the U.S. FDA for its manufacturing facility in Indore. The letter follows an inspection in February...
